Prix bas
CHF233.60
Impression sur demande - l'exemplaire sera recherché pour vous.
This contributed volume provides a comprehensive, in-depth and subject-based reviews on the current status of active ingredients, sustainable use, biodiversity and conservation of certain endangered medicinal plants. The book also explores conventional and non-conventional biotechnological interventions for their biodiversity conservation. Medicinal plants have been used in worldwide as a major source of raw material for the traditional herbal healthcare practices as well as for drug discovery and development in pharmaceutical industry. The cumulative consequences of various human activities and environmental factors cause decline in the biodiversity of medicinal plants at an unprecedented rate worldwide. Thus, the overall understanding of ecology, species and genetic diversity along with assessment of the status of different threats and their impact on medicinal plants is crucial to sustain existing biodiversity, its utilization and conservation. All the latest advancements in the biotechnological approaches for the conservation research of endangered medicinal plants and the future perspectives have been described. This book provides comprehensive reviews spreading over about 25 chapters divided in three sections. The chapters of this book are written by recognized scientists in their respective fields which are useful to students, academicians, researchers, botanists, biotechnologists, policy makers, conservationists and industries interested in biodiversity conservation and medicinal plant research for the production of secondary metabolites.
Covers the latest advancement in biodiversity conservation strategies for medicinal plant Describes the potential roles of medicinal plants for the treatment of COVID-19 Valuable resource for those who work on medicinal plants, phytochemistry and pharmaceutical industry
Auteur
Professor. Sumita Jha (nee Mukherjee), FNASc., FWAST, received her M.Sc. (1975) and Ph.D. (1981) from the University of Calcutta, Kolkata. She joined the same University as UGC Research Scientist in 1985 and as a faculty member in Botany in 1990. She was appointed Associate Professor in 1993 and became Professor in 2001. She has been involved in teaching courses on plant biology, molecular genetics, and biotechnology. Prof. Jha's group has developed transgenic cell and organ cultures in a number of rare, endangered indigenous medicinal plants for the production of high-value pharmaceuticals. Dr. Mihir Halder, Assistant Professor in the Post Graduate Department of Botany, Barasat Government College, West Bengal, India, received his B.Sc. with honors in Botany (2007) from Presidency College, Kolkata and M. Sc. in Botany (2009) from University of Calcutta, India. He was awarded Ph.D. in Biochemistry (2017) from University of Calcutta. He is actively engaged in teaching courses on Genetics, Cell and Molecular Biology and Plant Biotechnology for over seven years. His research interest includes medicinal plant biotechnology and cytogenetics.
Contenu